Favipiravir (CAS 259793-96-9) is a broad-spectrum antiviral agent with the molecular formula C5H4FN3O2 and a molecular weight of 157.1 g/mol. Our product is supplied as a white to off-white crystalline powder with a purity of ≥98% (HPLC). It is stored under 2-8°C conditions to ensure stability.
Favipiravir is primarily used for:
Dissolve Favipiravir in dimethyl sulfoxide (DMSO) or sterile water for in vitro studies. For clinical formulations, follow GMP protocols and regulatory guidelines.
Typical research dosage ranges from 100-300 mg/kg/day in preclinical studies. Adjust based on trial protocols.
Use PPE (gloves, goggles) during handling. Avoid inhalation or direct skin contact.
In 2020, Favipiravir was tested in clinical trials for COVID-19. A study showed a 7-day viral clearance rate of 88% in mild-to-moderate cases when administered at 1,800 mg twice daily on Day 1, followed by 800 mg twice daily.
Researchers used 200 mg/kg/day of Favipiravir in murine models to inhibit Ebola replication, achieving a 90% survival rate in early-stage infection.
In a Phase III trial, Favipiravir reduced influenza symptom duration by 29% compared to placebo when administered within 48 hours of onset.
Email: info@vivalr.com
Phone: (86) 15866781826
This is William, CEO of Zhishang Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.